Home › Sjogren's Syndrome › Illinois
Sjogren's Syndrome clinical trials in Illinois
5 studies for Sjogren's Syndrome are looking for participants at sites in Illinois.
Cities in Illinois
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Willow Rheumatology Wellness, Willowbrook
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07621809A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
- Chicago Clinical Research Inst, Chicago
- Willow Rheumatology Wellness, Willowbrook
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 25, 2026 · NCT07737743Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Chicago Clinical Research Institute Inc, Chicago
- Clinical Investigation Specialist, Schaumburg
- Willow Rheumatology & Wellness, Willowbrook
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 27, 2026 · NCT07404865AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Willowbrook, Willowbrook
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06991114The Myelin Disorders Biorepository Project
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RecruitingObservational study
All ages · All sexes · Updated Oct 23, 2025 · NCT03047369From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.